awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44808671-DE6FA1F2-EB39-4D6C-8BC2-B06959088976
Q44808671-DE6FA1F2-EB39-4D6C-8BC2-B06959088976
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44808671-DE6FA1F2-EB39-4D6C-8BC2-B06959088976
Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003?
P2860
Q44808671-DE6FA1F2-EB39-4D6C-8BC2-B06959088976
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44808671-DE6FA1F2-EB39-4D6C-8BC2-B06959088976
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eecfd7c82c9744779ec5dc4b50c654804c8af217
P2860
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthriti